CN1149298A - 通过马烯雌(甾)酮的酸性异构化得到马烯雌(甾)酮双键异构物 - Google Patents

通过马烯雌(甾)酮的酸性异构化得到马烯雌(甾)酮双键异构物 Download PDF

Info

Publication number
CN1149298A
CN1149298A CN95193322A CN95193322A CN1149298A CN 1149298 A CN1149298 A CN 1149298A CN 95193322 A CN95193322 A CN 95193322A CN 95193322 A CN95193322 A CN 95193322A CN 1149298 A CN1149298 A CN 1149298A
Authority
CN
China
Prior art keywords
bone
dehydro
rate
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95193322A
Other languages
English (en)
Chinese (zh)
Inventor
小F·Q·吉米尔
C·E·奥切希
S·J·阿德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of CN1149298A publication Critical patent/CN1149298A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN95193322A 1994-04-08 1995-04-06 通过马烯雌(甾)酮的酸性异构化得到马烯雌(甾)酮双键异构物 Pending CN1149298A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/224,849 1994-04-08
US08/224,849 US5395831A (en) 1994-04-08 1994-04-08 Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Publications (1)

Publication Number Publication Date
CN1149298A true CN1149298A (zh) 1997-05-07

Family

ID=22842497

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95193322A Pending CN1149298A (zh) 1994-04-08 1995-04-06 通过马烯雌(甾)酮的酸性异构化得到马烯雌(甾)酮双键异构物

Country Status (18)

Country Link
US (3) US5395831A (enExample)
EP (1) EP0754190B1 (enExample)
JP (1) JPH09511748A (enExample)
KR (1) KR970702291A (enExample)
CN (1) CN1149298A (enExample)
AT (1) ATE177111T1 (enExample)
AU (1) AU688029B2 (enExample)
CA (1) CA2186486A1 (enExample)
DE (1) DE69508068T2 (enExample)
DK (1) DK0754190T3 (enExample)
ES (1) ES2128051T3 (enExample)
GR (1) GR3030185T3 (enExample)
HU (1) HUT76338A (enExample)
IL (1) IL113178A (enExample)
NZ (1) NZ283951A (enExample)
TW (1) TW314468B (enExample)
WO (1) WO1995027724A1 (enExample)
ZA (1) ZA952771B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12234536B2 (en) 2022-12-03 2025-02-25 Arthur Craig Reardon High speed steel composition

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
AU7013296A (en) * 1995-08-30 1997-03-19 Eli Lilly And Company N-butylsulfonate esters of estrogens
ZA968873B (en) 1995-11-06 1997-05-28 Akzo Nobel Nv Isomerisation of equillin
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
EP0785212A1 (en) * 1996-01-22 1997-07-23 Laboratoire Theramex New 19-nor-pregnene derivatives
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
EP1330467B1 (en) 2000-11-03 2007-05-02 Washington University Modified, hydroxy-substituted aromatic structures having cytoprotective activity
US20020132802A1 (en) * 2000-11-17 2002-09-19 Washington Univeristy Cytoprotective polycyclic compounds
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
WO2003084978A1 (en) * 2002-04-01 2003-10-16 University Of Florida Steroidal quinols as prodrugs of antioxidants
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy
US7186707B2 (en) 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE205169C (enExample) *
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
US3391170A (en) * 1965-09-21 1968-07-02 Smith 13-alkylogona-1, 3, 5 (10), 9 (11)-tetraenes
US3385872A (en) * 1966-08-29 1968-05-28 Syntex Corp Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3471528A (en) * 1968-02-21 1969-10-07 Lilly Co Eli Method for producing delta**9(11) unsaturation in estrone and related compound
US3542819A (en) * 1968-06-11 1970-11-24 American Home Prod Process for preparing 8-isoestrone
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
US3689512A (en) * 1970-10-06 1972-09-05 American Home Prod Novel 3-etherified-1,3,5(10)-triene-steroids and process thereof
DE3014120A1 (de) * 1980-04-12 1981-10-29 Hoechst Ag, 6000 Frankfurt Verfahren zur synthese von oestron bzw. oestronderivaten
DD205169A1 (de) * 1982-05-26 1983-12-21 Adw Ddr Verfahren zur herstellung von 9(11)-dehydro-oestra-1,3,5(10)-trienen
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12234536B2 (en) 2022-12-03 2025-02-25 Arthur Craig Reardon High speed steel composition

Also Published As

Publication number Publication date
EP0754190B1 (en) 1999-03-03
EP0754190A1 (en) 1997-01-22
HUT76338A (en) 1997-08-28
DE69508068T2 (de) 1999-10-28
US5496814A (en) 1996-03-05
WO1995027724A1 (en) 1995-10-19
JPH09511748A (ja) 1997-11-25
ATE177111T1 (de) 1999-03-15
GR3030185T3 (en) 1999-08-31
TW314468B (enExample) 1997-09-01
IL113178A0 (en) 1995-06-29
US5395831A (en) 1995-03-07
HU9602755D0 (en) 1996-11-28
ES2128051T3 (es) 1999-05-01
CA2186486A1 (en) 1995-10-19
KR970702291A (ko) 1997-05-13
DE69508068D1 (de) 1999-04-08
IL113178A (en) 2000-07-26
AU688029B2 (en) 1998-03-05
DK0754190T3 (da) 1999-09-27
AU2242195A (en) 1995-10-30
NZ283951A (en) 1998-07-28
ZA952771B (en) 1996-10-04
US5552395A (en) 1996-09-03

Similar Documents

Publication Publication Date Title
CN1149298A (zh) 通过马烯雌(甾)酮的酸性异构化得到马烯雌(甾)酮双键异构物
KR20150013232A (ko) 골형성 및 헤지호그 신호전달을 유도하고 지방생성을 억제하는 옥시스테롤 유사체 oxy133
CN1383381A (zh) 一种含有五羟黄酮衍生物活性成分的骨质疏松症治疗剂
JPH0772138B2 (ja) 骨質量増加用医薬複合剤
JPH03504508A (ja) 新規な１α―ヒドロキシビタミンＤ２エピマー、その誘導体及びそれらを含んでなる調剤
DE69431965T2 (de) Wirkstoff gegen fettsucht
Napoli et al. 1-Fluorovitamin D3, a vitamin D3 analog more active on bone-calcium mobilization than on intestinal-calcium transport
CN1133450C (zh) 一种预防和治疗骨质疏松及促进骨折愈合的药物及其生产方法
DE60223707T2 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
JP2006515276A (ja) 骨粗鬆症の予防及び治療効果を有するフラン誘導体並びにこれを含む薬学的組成物
US3213086A (en) 7-methyl-delta4-androstene compounds
Al-Saleem et al. Levels of mercury and pathological changes in patients with organomercury poisoning
CN1193750C (zh) 一种治疗更年期综合症的药物
CN109805390A (zh) 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
KR102295111B1 (ko) 대사성 골질환 또는 갱년기 증상 예방 또는 치료용 조성물
US4323496A (en) Innoxious interferon-inducing substance, inducing agent and process for producing same
EP4119544A1 (en) Novel oxidized lappaconitine derivative and use thereof
JPH09507079A (ja) 疾患を仲介するためのビタミンｄ▲下３▼類似体と経路
EP1023445A1 (de) Cadherin derived growth factor und seine verwendung
GB2042549A (en) 25 - hydroxy-cholecalciferol - 26,23 - lactone
Stöß et al. Heterogeneity of osteogenesis imperfecta. Biochemical and morphological findings in a case of type III according to Sillence
CN106008256A (zh) 一种具有趋骨性的去铁敏衍生化合物及其制备方法和应用
CN115006382A (zh) 肉豆蔻酸在制备用于抗老年性骨质疏松药物中的应用
JPH02142792A (ja) 新規なベンゾフロキノリン誘導体
JPS6034544B2 (ja) ２４−ヒドロキシイソタキステロ−ル↓３及びその製造法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication